^
Association details:
Biomarker:MELK overexpression
Cancer:Hepatocellular Cancer
Drug Class:Immunotherapy
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Title:

Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma

Published date:
05/27/2022
Excerpt:
This study was aimed to explore the impact of MELK on HCC….Higher MELK expression was correlated with poorer survival and advanced clinical stage, topography (T) stage, and histological grade.
DOI:
10.3389/fcell.2022.824938